{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:58:26Z","timestamp":1791079106700,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":728,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/1469-0691.12042","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T21:46:57Z","timestamp":1348609617000},"page":"68-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"S7","title":["ESCMID \n\t\t  guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS"],"prefix":"10.1016","volume":"18","author":[{"given":"O.","family":"Lortholary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Petrikkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Garbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Meersseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Ullmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12042_bib1","series-title":"Essential of Clinical Mycology","first-page":"525","article-title":"Fungal infections among Patients with AIDS","author":"Lortholary","year":"2011"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12042_bib2","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1093\/clinids\/21.Supplement_1.S99","article-title":"Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities","volume":"21","author":"Reef","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1468-1293.2008.00554.x","article-title":"Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy","volume":"9","author":"Grabar","year":"2008","journal-title":"HIV Med"},{"key":"10.1111\/1469-0691.12042_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1310\/T7A7-1E63-2KA0-JKWD","article-title":"Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV\/AIDS patients","volume":"1","author":"Vazquez","year":"2000","journal-title":"HIV Clin Trials"},{"key":"10.1111\/1469-0691.12042_bib5","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1128\/jcm.34.9.2246-2254.1996","article-title":"Frequency, intensity, species, and strains of oral Candida vary as a function of host age","volume":"34","author":"Kleinegger","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12042_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/313765","article-title":"Refractory mucosal candidiasis in advanced human immunodeficiency virus infection","volume":"30","author":"Fichtenbaum","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/infdis\/173.1.219","article-title":"Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients","volume":"173","author":"Maenza","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/24.1.28","article-title":"Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology","volume":"24","author":"Maenza","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jac\/dkf101","article-title":"Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial","volume":"50","author":"Pagani","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12042_bib10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00002030-199709000-00003","article-title":"Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates","volume":"11","author":"Dromer","year":"1997","journal-title":"AIDS"},{"key":"10.1111\/1469-0691.12042_bib11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jac\/dkf233","article-title":"Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy","volume":"50","author":"Barchiesi","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12042_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/317936","article-title":"The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women","volume":"183","author":"Sobel","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/515554","article-title":"Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients","volume":"25","author":"Martins","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12042_bib14","first-page":"S96","article-title":"Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients","volume":"3","author":"Coleman","year":"1997","journal-title":"Oral Dis"},{"key":"10.1111\/1469-0691.12042_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0030-4220(92)90191-R","article-title":"Oral mycoses in HIV infection","volume":"73","author":"Samaranayake","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"Suppl 7","key":"10.1111\/1469-0691.12042_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID Diagnostic and Management Guidelines of Candida Diseases 2012: Diagnostic Procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12042_bib17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199503163321102","article-title":"A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group","volume":"332","author":"Powderly","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12042_bib18","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/515018","article-title":"Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS","volume":"27","author":"Havlir","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-126-9-199705010-00003","article-title":"Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"126","author":"Schuman","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1111\/1469-0691.12042_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archinte.1997.00440220068009","article-title":"Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection","volume":"157","author":"Manfredi","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1111\/1469-0691.12042_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/514744","article-title":"Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"McKinsey","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dki473","article-title":"Fluconazole for the management of invasive candidiasis: where do we stand after 15 years","volume":"57","author":"Charlier","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12042_bib23","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(89)92572-5","article-title":"Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS","volume":"1","author":"De Wit","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12042_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02681218880000081","article-title":"Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients","volume":"26","author":"Dupont","year":"1988","journal-title":"J Med Vet Mycol"},{"key":"10.1111\/1469-0691.12042_bib25","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.34.11.2267","article-title":"Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus","volume":"34","author":"Koletar","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12042_bib26","first-page":"1311","article-title":"Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group","volume":"6","author":"Pons","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/1469-0691.12042_bib27","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1086\/513664","article-title":"Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions","volume":"24","author":"Pons","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(94)90300-X","article-title":"Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance","volume":"97","author":"Sangeorzan","year":"1994","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12042_bib29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3476(95)70321-7","article-title":"Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group","volume":"127","author":"Flynn","year":"1995","journal-title":"J Pediatr"},{"key":"10.1111\/1469-0691.12042_bib30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF01974616","article-title":"Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group","volume":"13","author":"Hernandez-Sampelayo","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/516315","article-title":"Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues","volume":"26","author":"Darouiche","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00126334-200402010-00007","article-title":"Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis","volume":"35","author":"Van Roey","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/1469-0691.12042_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1310\/hct1104-186","article-title":"Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad(R) efficacy and safety (SMiLES)","volume":"11","author":"Vazquez","year":"2010","journal-title":"HIV Clin Trials"},{"key":"10.1111\/1469-0691.12042_bib34","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/cid\/cis205","article-title":"Miconazole mucoadhesive tablets: a novel delivery system","volume":"54","author":"Vazquez","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)00307-0","article-title":"Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV\/AIDS patients","volume":"104","author":"Graybill","year":"1998","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12042_bib36","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516342","article-title":"A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS","volume":"26","author":"Phillips","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib37","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/598361","article-title":"Treatment of thrush with itraconazole solution: evidence for topical effect","volume":"26","author":"Mascarenas","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib38","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AAC.37.4.778","article-title":"Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers","volume":"37","author":"Barone","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12042_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jac\/40.4.517","article-title":"Unresponsive HIV-related oro-oesophageal candidosis - an evaluation of two new in-vitro azole susceptibility tests","volume":"40","author":"Cartledge","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12042_bib40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV\/AIDS","volume":"42","author":"Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib41","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JCM.38.4.1563-1568.2000","article-title":"Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations","volume":"38","author":"Pelletier","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12042_bib42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000239469","article-title":"Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group","volume":"42","author":"de Repentigny","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1111\/1469-0691.12042_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/0003-4819-109-6-471","article-title":"Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS)","volume":"109","author":"Lake-Bakaar","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1111\/1469-0691.12042_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0732-8893(98)00107-2","article-title":"Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure","volume":"32","author":"Milan","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib45","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/00002030-199111000-00014","article-title":"Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV","volume":"5","author":"Smith","year":"1991","journal-title":"AIDS"},{"key":"10.1111\/1469-0691.12042_bib46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/00365549509047076","article-title":"Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study","volume":"27","author":"Barbaro","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib47","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1053\/gast.1996.v111.pm8898629","article-title":"Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis","volume":"111","author":"Barbaro","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1111\/1469-0691.12042_bib48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-117-8-655","article-title":"Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial","volume":"117","author":"Laine","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1111\/1469-0691.12042_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/514028","article-title":"A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis","volume":"176","author":"Wilcox","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib50","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1378\/chest.110.6.1507","article-title":"Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group","volume":"110","author":"Barbaro","year":"1996","journal-title":"Chest"},{"key":"10.1111\/1469-0691.12042_bib51","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/322653","article-title":"A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients","volume":"33","author":"Ally","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-2007-1005717","article-title":"Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study","volume":"27","author":"Barbaro","year":"1995","journal-title":"Endoscopy"},{"key":"10.1111\/1469-0691.12042_bib53","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01191-9","article-title":"A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis","volume":"113","author":"Villanueva","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12042_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.46.2.451-457.2002","article-title":"Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases","volume":"46","author":"Arathoon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12042_bib55","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/423377","article-title":"A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients","volume":"39","author":"de Wet","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-2036.2005.02427.x","article-title":"A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis","volume":"21","author":"de Wet","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/1469-0691.12042_bib57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/423378","article-title":"A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis","volume":"39","author":"Krause","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib58","first-page":"89","article-title":"Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection","volume":"2","author":"Vazquez","year":"2010","journal-title":"HIV AIDS (Auckl)"},{"key":"10.1111\/1469-0691.12042_bib59","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/AAC.37.11.2449","article-title":"Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1","volume":"37","author":"Cameron","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12042_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib61","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/00002030-200005050-00011","article-title":"Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295","volume":"14","author":"Fichtenbaum","year":"2000","journal-title":"AIDS"},{"key":"10.1111\/1469-0691.12042_bib62","doi-asserted-by":"crossref","first-page":"332","DOI":"10.7326\/0003-4819-126-4-199702150-00020","article-title":"Fluconazole suspension for oropharyngeal candidiasis unresponsive to tablets","volume":"126","author":"Martins","year":"1997","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12042_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1439-0507.1996.tb00514.x","article-title":"Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis","volume":"39","author":"Eichel","year":"1996","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12042_bib64","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00002030-199610000-00009","article-title":"Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility","volume":"10","author":"Phillips","year":"1996","journal-title":"AIDS"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12042_bib65","first-page":"S16","article-title":"Itraconazole oral solution: pharmacokinetics and absorption","volume":"11","author":"Saag","year":"1997","journal-title":"AIDS Patient Care STDS"},{"key":"10.1111\/1469-0691.12042_bib66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/511039","article-title":"Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection","volume":"44","author":"Skiest","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1310\/hct0802-86","article-title":"Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection","volume":"8","author":"Vazquez","year":"2007","journal-title":"HIV Clin Trials"},{"key":"10.1111\/1469-0691.12042_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/AAC.41.3.575","article-title":"In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection","volume":"41","author":"Ruhnke","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12042_bib69","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jac\/46.2.338","article-title":"Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis","volume":"46","author":"Muller","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12042_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00126334-200210010-00009","article-title":"Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole","volume":"31","author":"Kartsonis","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/1469-0691.12042_bib71","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jac\/dkh179","article-title":"Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study","volume":"53","author":"Kartsonis","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12042_bib72","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0b013e31817af47a","article-title":"A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis","volume":"48","author":"Vazquez","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/1469-0691.12042_bib73","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s100960050185","article-title":"Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal candidiasis in AIDS patients","volume":"17","author":"Vazquez","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib74","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJM199606203342516","article-title":"Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir","volume":"334","author":"Zingman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12042_bib75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0163-4453(90)90646-P","article-title":"Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study","volume":"21","author":"Leen","year":"1990","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12042_bib76","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.1991.00400120096018","article-title":"Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily","volume":"151","author":"Stevens","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1111\/1469-0691.12042_bib77","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF02005444","article-title":"Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients","volume":"10","author":"Just-Nubling","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib78","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.1993.tb121784.x","article-title":"Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study","volume":"158","author":"Marriott","year":"1993","journal-title":"Med J Aust"},{"key":"10.1111\/1469-0691.12042_bib79","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1086\/497373","article-title":"A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323\/Mycoses Study Group Study 40","volume":"41","author":"Goldman","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12042_bib80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1034\/j.1600-0714.2002.310308.x","article-title":"Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London","volume":"31","author":"Eyeson","year":"2002","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/1469-0691.12042_bib81","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/moe.2001.118902","article-title":"The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study","volume":"92","author":"Tappuni","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/1469-0691.12042_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005792-200301000-00004","article-title":"The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico","volume":"82","author":"Ramirez-Amador","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/1469-0691.12042_bib83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1601-0825.2005.01214.x","article-title":"Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients","volume":"12","author":"Miziara","year":"2006","journal-title":"Oral Dis"},{"key":"10.1111\/1469-0691.12042_bib84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tripleo.2004.06.081","article-title":"Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina","volume":"99","author":"Chattopadhyay","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"Suppl 7","key":"10.1111\/1469-0691.12042_bib85","first-page":"1","article-title":"ESCMID Diagnostic and Management Guideline for Candida Diseases 2012: Developing European Guidelines","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clinical Microbiology and Infectious Diseases"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14607680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14607680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:13:44Z","timestamp":1761117224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14607680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":85,"alternative-id":["S1198743X14607680"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12042","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESCMID\n\t\t guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1469-0691.12042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}